Zentalis Pharmaceuticals Inc

NASDAQ:ZNTL   4:00:00 PM EDT
20.65
-0.98 (-4.53%)
5:00:01 PM EDT: $21.68 +1.03 (+4.99%)
Earnings Announcements

Zentalis Pharmaceuticals Reports Q3 2022 Financial Results

Published: 11/09/2022 12:24 GMT
Zentalis Pharmaceuticals Inc (ZNTL) - Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates.
$422 Million Cash Balance As of September 30, , With Projected Cash Runway Into 2025.
Qtrly Loss per Share $0.96.
Q3 Earnings per Share View $-1.17-- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.06

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.03

More details on our Analysts Page.